🔗 Permalink

Inventor profile of:

Sina Bavari

City:

Frederick, Maryland

Country:

United States

Published Applications:

Last publication date:

2023-05-11

Top Assignees for applications by Sina Bavari

The entities that hold a legal rights for patent applications filed by inventor Bavari Sina:

The United States of America as Represented by the Secretary of the Army 12 Washington, DC United States
ALNYLAM PHARMACEUTICALS, INC. 7 Cambridge, MA United States
AVI BIOPHARMA, INC. 5 Corvallis, OR United States
U.S. ARMY MEDICAL RESEARCH AND MATERIAL COMMAND 2 FREDERICK, MD United States
THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY 1 Frederick, MD United States
The Government of the United States, as Represented by the Secretary of the Army 1 Washington, DC United States
GOVERNMENT OF THE UNITED STATES 1 Frederick, MD United States
The United States of America as represented by the Secretary of the Department of Health and Human Services, National Institutes of Health 1 Washington, DC United States
The United States of America as represemted by the Secretary of the Army 1 Washington, DC United States
The Government of the United States of America as Represented by the Secretary of The Dept of HHS 1 Rockville, MD United States
The United States of America as Represented by the Army 1 Washington, DC United States
UNITED STATES DEPARTMENT OF THE ARMY, AS REPRESENTED BY THE SECRETARY OF THE ARMY 1 Fort Detrick, MD United States
The United States of America as represented by the Army Medical Research and Material Command 1 Washington, DC United States
US ARMY MEDICAL RESEARCH AND MATERIEL COMMAND 1 FORT DETRICK, MD United States
HEALION BIO., INC. 1 Frederick, MD United States

Recent patent applications by Bavari Sina

Sina Bavari from Frederick, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-05-11

US20230142126A1

Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL DISEASES

#2 | 2017-09-28

US20170274063A1

Human necessities

THERMOSTABLE, CHROMATOGRAPHICALLY PURIFIED NANO-VLP VACCINE

#3 | 2016-09-15

US20160264972A1

Chemistry; metallurgy

Compositions and Methods for Inhibiting Expression of a Gene from the Ebola Virus

#4 | 2015-12-03

US20150346215A1

Physics

FILOVIRUS FUSION PROTEINS AND THEIR USES

#5 | 2015-04-02

US20150093417A1

Chemistry; metallurgy

Compositions And Methods For Inhibiting Expression Of CD45 Gene

#6 | 2014-08-28

US20140243394A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of a gene from the Ebola virus

#7 | 2013-12-05

US20130323243A1

Human necessities

Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an immunoglobulin heavy chain constant region

#8 | 2013-08-29

US20130225654A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of a gene from the Ebola virus

#9 | 2013-03-14

US20130065943A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of CD45 gene

#10 | 2012-05-31

US20120135013A1

Human necessities

CD45 and Methods and Compounds Related Thereto

#11 | 2012-05-17

US20120122127A1

Chemistry; metallurgy

Cleavage sensitive antibodies and methods of use thereof

#12 | 2012-02-09

US20120035198A1

Human necessities

Antiviral Compounds and Methods of Using Thereof

#13 | 2011-11-17

US20110280904A1

Human necessities

Generation of virus-like particles and use as panfilovirus vaccine

#14 | 2011-08-18

US20110201671A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of a gene from the ebola virus

#15 | 2011-04-14

US20110086877A1

Human necessities

Small Molecule Inhibitors of Botulinum Neurotoxins

#16 | 2011-03-10

US20110060031A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of a gene from the ebola virus

#17 | 2011-02-10

US20110034537A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of CD45 gene

#18 | 2010-11-11

US20100285055A1

Chemistry; metallurgy

Activation of natural killer (NK) cells and methods of use

#19 | 2010-06-10

US20100143409A1

Chemistry; metallurgy

Generation of virus-like particles and use as panfilovirus vaccines

#20 | 2009-07-23

US20090186849A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#21 | 2009-07-23

US20090186848A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#22 | 2009-07-23

US20090186847A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#23 | 2009-06-04

US20090143323A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of a gene from the Ebola

#24 | 2009-01-08

US20090012107A1

Human necessities

Antiviral compounds and methods of using thereof

#25 | 2007-05-17

US20070112049A1

Human necessities

Small molecule inhibitors of botulinum neurotoxins

#26 | 2007-05-17

US20070112048A1

Human necessities

Broad spectrum antibacterial compounds

#27 | 2006-12-14

US20060281701A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#28 | 2006-09-14

US20060205693A1

Chemistry; metallurgy

Antisense antiviral compounds and methods for treating a filovirus infection

#29 | 2006-08-10

US20060177881A1

Chemistry; metallurgy

Antibodies against type A botulinum neurotoxin

#30 | 2006-05-23

US10655450

Antibodies against type a botulinum neurotoxin

#31 | 2006-05-11

US20060099609A1

Chemistry; metallurgy

Activation of natural killer (NK) cells and methods of use

#32 | 2006-05-11

US20060099225A1

Chemistry; metallurgy

Generation of virus-like particles and use as panfilovirus vaccine

#33 | 2005-12-01

US20050266023A1

Chemistry; metallurgy

Generation of virus-like particles and use as panfilovirus vaccine

#34 | 2005-11-10

US20050251345A1

Chemistry; metallurgy

Inhibition of anthrax lethal factor protease

#35 | 2005-07-14

US20050153945A1

Human necessities

Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof

InventorID:

141218 ⎘